Paper23908333
Cardioprotection and myocardial reperfusion: pitfalls to clinical application.
Vander Heide RS and 1 other. Circ Res, 2013. Cited by 102 papers, by iCite.
Cite this record
ConductScience Library. Cardioprotection and myocardial reperfusion: pitfalls to clinical application. Papers, record 23908333. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23908333
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiotonic Agents | Major topic |
| Myocardial Infarction | Major topic |
| Myocardial Reperfusion Injury | Major topic |
| Translational Research, Biomedical | Major topic |
| Animals | |
| Clinical Trials as Topic | |
| Disease Models, Animal | |
| Humans | |
| Severity of Illness Index | |
| Time Factors |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL039752 | NHLBI NIH HHS | United States | R01HL039752 | PubMed and NIH | NIH RePORTER |
| R21 HL098786 | NHLBI NIH HHS | United States | R21HL098786 | PubMed and NIH | NIH RePORTER |
| 5R01 HL039752 | NHLBI NIH HHS | United States | R01HL039752 | PubMed and NIH | NIH RePORTER |
References84
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21454053 | Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols. | Nutrition | 2011 | https://conductscience.org/library/papers/21454053 | PubMed |
| 2 | 691070 | The oxygen paradox and the calcium paradox: two facets of the same problem? | J Mol Cell Cardiol | 1978 | https://conductscience.org/library/papers/691070 | PubMed |
| 3 | 11733394 | Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. | Circulation | 2001 | https://conductscience.org/library/papers/11733394 | PubMed |
| 4 | 17299242 | Caldaret, an intracellular Ca2+ handling modulator, limits infarct size of reperfused canine heart. | J Pharmacol Sci | 2007 | https://conductscience.org/library/papers/17299242 | PubMed |
| 5 | 14962476 | New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. | Cardiovasc Res | 2004 | https://conductscience.org/library/papers/14962476 | PubMed |
| 6 | 3664998 | Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. | Circulation | 1987 | https://conductscience.org/library/papers/3664998 | PubMed |
| 7 | 16497286 | Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. | Cardiovasc Res | 2006 | https://conductscience.org/library/papers/16497286 | PubMed |
| 8 | 19903682 | Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52,693 patients in the Global Registry of Acute Coronary Events. | Eur Heart J | 2010 | https://conductscience.org/library/papers/19903682 | PubMed |
| 9 | 6331179 | Myocardial alterations due to free-radical generation. | Am J Physiol | 1984 | https://conductscience.org/library/papers/6331179 | PubMed |
| 10 | 18025468 | Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/18025468 | PubMed |
| 11 | 4814895 | Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow. | Am J Pathol | 1974 | https://conductscience.org/library/papers/4814895 | PubMed |
| 12 | 18519850 | Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction. | Circulation | 2008 | https://conductscience.org/library/papers/18519850 | PubMed |
| 13 | 5291154 | Ischemic injury of myocardium. | Ann N Y Acad Sci | 1969 | https://conductscience.org/library/papers/5291154 | PubMed |
| 14 | 3769170 | Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. | Circulation | 1986 | https://conductscience.org/library/papers/3769170 | PubMed |
| 15 | 23415552 | Activation of the homeostatic intracellular repair response during cardiac surgery. | J Am Coll Surg | 2013 | https://conductscience.org/library/papers/23415552 | PubMed |
| 16 | 15841216 | Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15841216 | PubMed |
| 17 | 3339135 | Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. | J Clin Invest | 1988 | https://conductscience.org/library/papers/3339135 | PubMed |
| 18 | 16186417 | Postconditioning the human heart. | Circulation | 2005 | https://conductscience.org/library/papers/16186417 | PubMed |
| 19 | 2548761 | Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. | Circ Res | 1989 | https://conductscience.org/library/papers/2548761 | PubMed |
| 20 | 16782719 | Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. | Eur Heart J | 2006 | https://conductscience.org/library/papers/16782719 | PubMed |
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 102 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42534919 | Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42534919 | PubMed |
| 41826738 | Insights in ischemia/reperfusion injury and cardioprotection: neglected and emerging pathways and therapeutic targets for a personalized therapy. | Basic Res Cardiol | 2026 | https://conductscience.org/library/papers/41826738 | PubMed |
| 41779091 | Cardioprotection Through Mitochondrial Modulation: A Systematic Review of Pharmacological Interventions in Animal Models of I/R Injury. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/41779091 | PubMed |
| 41648342 | Asporin Improves Cardiac Myocyte Response to Ischemia and Reperfusion Stress. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648342 | PubMed |
| 41645903 | TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn2+ Homeostasis. | Circulation | 2026 | https://conductscience.org/library/papers/41645903 | PubMed |
| 41286379 | Extracellular vesicles in cardiac surgery: unlocking new frontiers in cardioprotection and patient outcomes. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/41286379 | PubMed |
| 41007647 | Cardiac Ischaemia-Reperfusion Injury: Pathophysiology, Therapeutic Targets and Future Interventions. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007647 | PubMed |
| 40801651 | Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease? | Cells | 2025 | https://conductscience.org/library/papers/40801651 | PubMed |
| 40722608 | Network Pharmacology Approaches to Myocardial Infarction Reperfusion Injury: Exploring Mechanisms, Pathophysiology, and Novel Therapies. | Biomedicines | 2025 | https://conductscience.org/library/papers/40722608 | PubMed |
| 40433738 | Specialized Pro-Resolving Mediators as Emerging Players in Cardioprotection: From Inflammation Resolution to Therapeutic Potential. | Acta Physiol (Oxf) | 2025 | https://conductscience.org/library/papers/40433738 | PubMed |
| 40332433 | Pharmacologic ROMK Inhibition Protects Against Myocardial Ischemia Reperfusion Injury. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332433 | PubMed |
| 39300122 | Pyroptosis in health and disease: mechanisms, regulation and clinical perspective. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39300122 | PubMed |
| 38906975 | Inhibition of the protective effects of preconditioning in ischemia-reperfusion injury by chronic methadone: the role of pAkt and pSTAT3. | Sci Rep | 2024 | https://conductscience.org/library/papers/38906975 | PubMed |
| 38516440 | Japanese Traditional Herbal Medicine, Rikkunshito, Partially Suppresses Inflammatory Responses in Myocardial Ischemia/Reperfusion Injury. | Cureus | 2024 | https://conductscience.org/library/papers/38516440 | PubMed |
| 37966667 | Protective effect of canagliflozin on post-resuscitation myocardial function in a rat model of cardiac arrest. | Intensive Care Med Exp | 2023 | https://conductscience.org/library/papers/37966667 | PubMed |
| 37814087 | Splenic monocytes mediate inflammatory response and exacerbate myocardial ischemia/reperfusion injury in a mitochondrial cell-free DNA-TLR9-NLRP3-dependent fashion. | Basic Res Cardiol | 2023 | https://conductscience.org/library/papers/37814087 | PubMed |
| 36742214 | A Systematic Review with Meta-Analysis Investigating the Impact of Targeted Perfusion Parameters during Extracorporeal Cardiopulmonary Resuscitation in Out-of-Hospital and Inhospital Cardiac Arrest. | J Extra Corpor Technol | 2022 | https://conductscience.org/library/papers/36742214 | PubMed |
| 36300202 | Multi‑faceted roles of cathepsins in ischemia reperfusion injury (Review). | Mol Med Rep | 2022 | https://conductscience.org/library/papers/36300202 | PubMed |
| 34360579 | Bmi1 Augments Proliferation and Survival of Cortical Bone-Derived Stem Cells after Injury through Novel Epigenetic Signaling via Histone 3 Regulation. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34360579 | PubMed |
| 34056918 | Nanoparticle-Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia-Reperfusion Injury. | J Am Heart Assoc | 2021 | https://conductscience.org/library/papers/34056918 | PubMed |
Genes26
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23908333
GET https://conductscience.org/api/papers/v1/23908333/references?page=2